CLDF Title
Home | Contact Us | Bookmark
HBV HE HCC HCV
About CLDF Centers of Educational Expertise  
CME Dinner Meetings Telewebs Webcasts Slide Library Abstract Library Conference Highlights
 
Back  
 
Reuters Health Information (2005-09-22): Liver transplantation possible without blood transfusions

Clinical

Liver transplantation possible without blood transfusions

Last Updated: 2005-09-22 12:36:25 -0400 (Reuters Health)

NEW YORK (Reuters Health) - Surgeons in California have succeeded in routinely transplanting livers without using blood transfusions in the recipients. "If we can do liver transplantation, which is one of the most difficult surgeries in the abdomen to do without blood transfusion, then we can pretty much do almost any surgery in the abdomen without blood transfusions," Dr. Singh Gagandeep told Reuters Health.

In the Journal of the American College of Surgeons for September 5, Dr. Gagandeep and his colleagues at the University of Southern California-University Hospital in Los Angeles report the strategies they used to treat 24 adult Jehovah's Witness patients, whose religion forbids the use of blood transfusions.

The 19 patients who received transplants from living donors were treated with erythropoietin, iron sulfate and folic acid to build up their hematocrit. A transjugular intrahepatic portal-systemic shunt was used in seven patients to treat upper gastrointestinal bleeding or to decrease portal pressure.

"Then when you take them to the operating room, meticulous surgical technique has to be there, but over and above that there are things you can do that can curtail blood loss," Dr. Gagandeep said.

One measure is to salvage blood lost during surgery and to re-infuse it. Another is to maintain acute normovolemic hemodilution, he explained, "reconstituting the intravascular component with fluids and collagen crystalloids, so the patient doesn't go into shock."

Other strategies included monitoring the intraoperative coagulation profile with a thromboelastogram, and treating patients with recombinant factor VIIa or Amicar as necessary for containing coagulopathy.

Finally, the surgeon noted, blood draws to monitor the patients' progress after surgery are used "judiciously."

All the patients survived except for two who had severe kidney dysfunction.

In addition to the liver transplant recipients, Dr. Gagandeep said, "We have performed 81 living donor liver hepatectomies in which we used only one unit of blood in one patient, so we have gotten it down to an art form."

"We should look at blood conservation not as an art but as a science," he added. "No matter how safe we make blood donation, there will always be the risk of disease transmission."

In 10 to 15 years from now, he predicted, "we hopefully will not have to use blood products at all, substituting synthetic products instead."

J Am Coll Surg 2005;201:412-417.

 
 
 
 
                 
 
HBV
Webcasts
Slide Library
Abstract Library
 
HE
CME Dinner Meeting
Webcasts
Slide Library
Abstract Library
 
HCC
Slide Library
Abstract Library
 
 
HCV
Webcasts
Slide Library
Abstract Library
 
CLDF Follow Us
   
 
About CLDF
Mission Statement
Board of Trustees
Board of Advisors
CLDF Supporters
 
Other Resources
Liver News Library
Journal Abstracts
Hep C Link to Care
 
Centers of
Educational Expertise
Regional Map
     
   
  The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2014 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.